FDA Names Former Pharmaceutical Company Executive to Oversee US Drug Program

Why was a Big Pharma bigwig tapped for top FDA post?

Health and Human Services Secretary Robert F. Kennedy Jr. has been throwing a fit over Food and Drug Administration regulators for years.  Setting aside Kennedy’s congenital inability to tell the truth, the underlying sentiment is solid: Who wants drug regulations made by drug industry insiders? So you’d think that FDA Commissioner Marty Makary’s pick to run the Center for Drug Evaluation and Research, George Tidmarsh, would be free of such enta…

FDA Names George Tidmarsh as Top Drug Regulator

The Food and Drug Administration announced on July 21 that a former pharmaceutical executive will direct its drug evaluation center. Dr. George Tidmarsh, an adjunct professor at Stanford University, will lead the FDA’s Center for Drug Evaluation and Research (CDER), the FDA said in a statement. Tidmarsh was president and CEO of La Jolla Pharmaceutical Company from early 2012 until late 2019, during which time the company secured FDA approval of …

FDA Appoints Biotech Exec as Top Drug Regulator

FDA Appoints New CDER Director, George Tidmarsh

George Francis Tidmarsh, MD, PhD, founding co-director of Stanford’s Master of Translational Research and Applied Medicine program, has been appointed as the new director of the Center for Drug Evaluation and Research.

Biotech exec George Tidmarsh picked as FDA's chief drug regulator

The U.S. Food and Drug Administration named ex-biotech exec George Tidmarsh as its chief drug regulator. FDA Commissioner Marty Makary called Tidmarsh an "accomplished physician-scientist and leader."

FDA appoints biotech veteran George Tidmarsh to lead drug evaluation division

Stanford's George Tidmarsh has authored 143 scientific papers and patents, as well as played a central role in developing seven FDA-approved drugs.